Ubiquitin C-terminal hydrolase-L1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2044-2057

  Meyer Schwesinger, Catherine ^a   Meyer, Tobias N ^a   Sievert, Henning ^a   Hoxha, Elion ^a   Sachs, Marlies ^a   Klupp, Eva Maria ^a   Münster, Silvia ^a   Balabanov, Stefan ^a   Carrier, Lucie ^a,b,c   Helmchen, Udo ^a   Thaiss, Friedrich ^a   Stahl, Rolf A K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Sorbonne Université   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; MONOUBIQUITIN; POLYUBIQUITIN; PROTEASOME; UBIQUITIN; UBIQUITIN C TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE HEYMANN NEPHRITIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEINURIA; RAT; RECEPTOR DOWN REGULATION; UBIQUITINATION;

EID: 79959281220     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.017     Document Type: Article

References (56)

1. Kriz W, Kretzler M, Provoost AP, Shirato I: Stability and leakiness: opposing challenges to the glomerulus. Kidney Int 1996, 49:1570-1574 (Pubitemid 26186582)
2. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 2002, 13:3005-3015 (Pubitemid 35386921)
3. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998, 54:687-697
4. Kriz W, Kretzler M, Nagata M, Provoost AP, Shirato I, Uiker S, Sakai T, Lemley KV: A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res 1996, 19:245-253 (Pubitemid 26395311)
5. Couser WG, Nangaku M: Cellular and molecular biology of membranous nephropathy. J Nephrol 2006, 19:699-705 (Pubitemid 46415972)
6. Hochstrasser M: Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995, 7:215-223
7. Goldberg AL: Functions of the proteasome: the lysis at the end of the tunnel. Science 1995, 268:522-523
8. Kalderon D: Protein degradation: de-ubiquitinate to decide your fate. Curr Biol 1996, 6:662-665
9. Rolfe M, Chiu MI, Pagano M: The ubiquitin-mediated proteolytic pathway as a therapeutic area. J Mol Med 1997, 75:5-17 (Pubitemid 27067134)
10. Wilkinson KD: Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 1997, 11:1245-1256
11. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J: The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989, 246:670-673 (Pubitemid 19283361)
12. Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi M, Chain DG, Martin KC, Kandel ER, Schwartz JH: Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 1997, 89:115-126 (Pubitemid 27180591)
13. Sakurai M, Ayukawa K, Setsuie R, Nishikawa K, Hara Y, Ohashi H, Nishimoto M, Abe T, Kudo Y, Sekiguchi M, Sato Y, Aoki S, Noda M, Wada K: Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 2006, 119:162-171 (Pubitemid 43169309)
14. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr: The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002, 111:209-218 (Pubitemid 35292441)
15. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L: Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 2004, 279:13256-13264 (Pubitemid 38445905)
16. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, Moolman D, Zhang H, Shelanski M, Arancio O: Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126:775-788 (Pubitemid 44233627)
17. Chung KK, Dawson VL, Dawson TM: New insights into Parkinson's disease. J Neurol 2003, 250(Suppl 3):III15-III24
18. Shirato I, Asanuma K, Takeda Y, Hayashi K, Tomino Y: Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000, 11:2381-2386
19. Diomedi-Camassei F, Rava L, Lerut E, Callea F, Van Damme B: Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney. Nephrol Dial Transplant 2005, 20:2714-2719 (Pubitemid 41672270)
20. Franch HA: Pathways of proteolysis affecting renal cell growth. Curr Opin Nephrol Hypertens 2002, 11:445-450
21. Debigare R, Price SR: Proteolysis, the ubiquitin-proteasome system, and renal diseases. Am J Physiol Renal Physiol 2003, 285:F1-F8 (Pubitemid 36818456)
22. Meyer-Schwesinger C, Meyer TN, Munster S, Klug P, Saleem M, Helmchen U, Stahl RA: A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies. J Pathol 2009, 217:452-464
23. Salant DJ, Cybulsky AV: Experimental glomerulonephritis. Methods Enzymol 1988, 162:421-461 (Pubitemid 19019528)
24. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K: Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 2004, 66:91-101 (Pubitemid 38870085)
25. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE: A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298
26. Meyer-Schwesinger C, Dehde S, von Ruffer C, Gatzemeier S, Klug P, Wenzel UO, Stahl RA, Thaiss F, Meyer TN: Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling. Am J Physiol Renal Physiol 2009, 296: F1088-F1099
27. Meyer TN, Schwesinger C, Wahlefeld J, Dehde S, Kerjaschki D, Becker JU, Stahl RA, Thaiss F: A new mouse model of immune-mediated podocyte injury. Kidney Int 2007, 72:841-852 (Pubitemid 47462080)
28. Abramoff MMP, Ram SJ: Image processing with ImageJ. Biophotonics Int 2004, 11:36-42
29. Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RA, Thaiss F: Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 2006, 17:454-464
30. Bonegio RG, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, Lieberthal W: Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005, 16:2063-2072 (Pubitemid 41716437)
31. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, Yeh LA, Cuny GD, Stein RL, Lansbury PT Jr: Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol 2003, 10:837-846 (Pubitemid 37171901)
32. Kundu M, Thompson CB: Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008, 3:427-455 (Pubitemid 351488288)
33. Finley D, Ozkaynak E, Varshavsky A: The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell 1987, 48:1035-1046
34. Chernova TA, Allen KD, Wesoloski LM, Shanks JR, Chernoff YO, Wilkinson KD: Pleiotropic effects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool. J Biol Chem 2003, 278:52102-52115 (Pubitemid 38035796)
35. Papa FR, Hochstrasser M: The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 1993, 366:313-319 (Pubitemid 23349357)
36. Swaminathan S, Amerik AY, Hochstrasser M: The Doa4 deubiquitinating enzyme is required for ubiquitin homeostasis in yeast. Mol Biol Cell 1999, 10:2583-2594 (Pubitemid 29393512)
37. Chen Y, Piper PW: Consequences of the overexpression of ubiquitin in yeast: elevated tolerances of osmostress, ethanol and canavanine, yet reduced tolerances of cadmium, arsenite and paromomycin. Biochim Biophys Acta 1995, 1268:59-64
38. Wilkinson KD: Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol 2000, 11:141-148
39. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K: Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 1999, 23:47-51 (Pubitemid 29418786)
40. Das C, Hoang QQ, Kreinbring CA, Luchansky SJ, Meray RK, Ray SS, Lansbury PT, Ringe D, Petsko GA: Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc Natl Acad Sci USA 2006, 103:4675-4680
41. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, Sato Y, Nishikawa K, Sun YJ, Sakurai M, Harada T, Hara Y, Kimura I, Chiba S, Namikawa K, Kiyama H, Noda M, Aoki S, Wada K: Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003, 12:1945-1958 (Pubitemid 37038804)
42. Vigouroux S, Briand M, Briand Y: Linkage between the proteasome pathway and neurodegenerative diseases and aging. Mol Neurobiol 2004, 30:201-221 (Pubitemid 41271216)
43. Lansbury PT Jr: Improving synaptic function in a mouse model of AD. Cell 2006, 126:655-657
44. Wang YL, Liu W, Sun YJ, Kwon J, Setsuie R, Osaka H, Noda M, Aoki S, Yoshikawa Y, Wada K: Overexpression of ubiquitin carboxyl-terminal hydrolase L1 arrests spermatogenesis in transgenic mice. Mol Reprod Dev 2006, 73:40-49 (Pubitemid 41759950)
45. Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA: UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J Neurochem 2004, 90:379-391 (Pubitemid 38938224)
46. Piotrowski J, Beal R, Hoffman L, Wilkinson KD, Cohen RE, Pickart CM: Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J Biol Chem 1997, 272:23712-23721 (Pubitemid 27410947)
47. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, Li J, Li F, Gerdes AM, Wawrousek EF, Wang X: Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 2005, 97:1018-1026 (Pubitemid 41668915)
48. Liu J, Chen Q, Huang W, Horak KM, Zheng H, Mestril R, Wang X: Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J 2006, 20:362-364 (Pubitemid 46671172)
49. Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstadt H, Kerjaschki D, Mizushima N, Shaw AS, Walz G, Huber TB: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120:1084-1096
50. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study Am J Kidney Dis 2000, 35:157-165 (Pubitemid 30027256)
51. McNaught KS, Bjorklund LM, Belizaire R, Isacson O, Jenner P, Olanow CW: Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 2002, 13:1437-1441
52. McNaught KS, Olanow CW: Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiol Aging 2006, 27:530-545 (Pubitemid 43290522)
53. Apostol BL, Kazantsev A, Raffioni S, Illes K, Pallos J, Bodai L, Slepko N, Bear JE, Gertler FB, Hersch S, Housman DE, Marsh JL, Thompson LM: A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc Natl Acad Sci USA 2003, 100:5950-5955 (Pubitemid 36576913)
54. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361:11-21
55. Kerjaschki D, Neale TJ: Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 1996, 7:2518-2526 (Pubitemid 27469557)
56. Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG: Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 1989, 143:546-552 (Pubitemid 19191550)